Drug General Information
Drug ID
D0T7DV
Former ID
DNC013260
Drug Name
SODIUM ZINC DIHYDROLIPOYLHISTIDINATE
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528613]
Formula
C14H20N3NaO3S2Zn
Canonical SMILES
C1=C(NC=N1)CC(C(=O)[O-])NC(=O)CCCCC(CC[S-])[S-].[Na+].[<br />Zn+2]
InChI
1S/C14H23N3O3S2.Na.Zn/c18-13(4-2-1-3-11(22)5-6-21)17-12(14(19)20)7-10-8-15-9-16-10;;/h8-9,11-12,21-22H,1-7H2,(H,15,16)(H,17,18)(H,19,20);;/q;+1;+2/p-3
InChIKey
GLGKCICLFLDJDO-UHFFFAOYSA-K
PubChem Compound ID
Target and Pathway
Target(s) Tyrosine oxidase Target Info Inhibitor [528613]
BioCyc Pathway (S)-reticuline biosynthesis
Eumelanin biosynthesis
L-dopachrome biosynthesis
KEGG Pathway Tyrosine metabolism
Riboflavin metabolism
Metabolic pathways
Melanogenesis
PathWhiz Pathway Riboflavin Metabolism
Tyrosine Metabolism
WikiPathways Dopamine metabolism
References
Ref 528613Bioorg Med Chem. 2007 Mar 1;15(5):1967-75. Epub 2006 Dec 31.Modulating effects of a novel skin-lightening agent, alpha-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products.
Ref 528613Bioorg Med Chem. 2007 Mar 1;15(5):1967-75. Epub 2006 Dec 31.Modulating effects of a novel skin-lightening agent, alpha-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products.